TRDA Stock Overview
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.
Entrada Therapeutics, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$17.17|
|52 Week High||US$24.38|
|52 Week Low||US$5.12|
|1 Month Change||-22.13%|
|3 Month Change||19.65%|
|1 Year Change||-20.18%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-28.31%|
Recent News & Updates
|TRDA||US Biotechs||US Market|
Return vs Industry: TRDA underperformed the US Biotechs industry which returned -6.5% over the past year.
Return vs Market: TRDA underperformed the US Market which returned -17.6% over the past year.
|TRDA Average Weekly Movement||13.7%|
|Biotechs Industry Average Movement||11.1%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.7%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: TRDA is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week.
Volatility Over Time: TRDA's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company’s lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1.
Entrada Therapeutics, Inc. Fundamentals Summary
|TRDA fundamental statistics|
Is TRDA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|TRDA income statement (TTM)|
|Cost of Revenue||US$0|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-2.82|
|Net Profit Margin||0.00%|
How did TRDA perform over the long term?See historical performance and comparison